These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


187 related items for PubMed ID: 1321092

  • 1. Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group.
    Girardin E, Roux-Lombard P, Grau GE, Suter P, Gallati H, Dayer JM.
    Immunology; 1992 May; 76(1):20-3. PubMed ID: 1321092
    [Abstract] [Full Text] [Related]

  • 2. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
    Glossop JR, Dawes PT, Nixon NB, Mattey DL.
    Arthritis Res Ther; 2005 May; 7(6):R1227-34. PubMed ID: 16277675
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Enhanced expression and shedding of tumor necrosis factor (TNF) receptors from mononuclear leukocytes in human heart failure.
    Nozaki N, Yamaguchi S, Yamaoka M, Okuyama M, Nakamura H, Tomoike H.
    J Mol Cell Cardiol; 1998 Oct; 30(10):2003-12. PubMed ID: 9799654
    [Abstract] [Full Text] [Related]

  • 6. Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies.
    Ribbens C, André B, Kaye O, Kaiser MJ, Bonnet V, de Groote D, Franchimont N, Malaise MG.
    Eur Cytokine Netw; 2000 Dec; 11(4):669-76. PubMed ID: 11125312
    [Abstract] [Full Text] [Related]

  • 7. [Serum levels of tumor necrosis factor alpha and soluble tumor necrosis factor-receptor I in asthmatic patients and patients with chronic respiratory tract infection].
    Sumitomo M, Suda S, Shindo K, Fukumura M, Fukushima J, Okuda K, Ito A.
    Arerugi; 1997 Nov; 46(11):1136-47. PubMed ID: 9436331
    [Abstract] [Full Text] [Related]

  • 8. [Serum concentration and urinary excretion of soluble receptors for tumor necrosis factor in patients with primary glomerulonephritis].
    Kacprzyk F.
    Pol Merkur Lekarski; 2003 Oct; 15(88):383-6; discussion 386-7. PubMed ID: 14974372
    [Abstract] [Full Text] [Related]

  • 9. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis].
    Tesar V, Jirsa M, Masek Z, Bartůnková J, Stejskalová A, Dostál C, Zabka J, Chábová V, Rysavá R.
    Cas Lek Cesk; 1998 May 04; 137(9):271-5. PubMed ID: 9650355
    [Abstract] [Full Text] [Related]

  • 10. [Tumor necrosis factor alpha and its soluble receptors in serum of patients with coronary artery disease].
    Mizia-Stec K, Mandecki T, Zahorska-Markiewicz B, Janowska J, Szulc A, Jastrzebska-Maj E, Szymański L.
    Pol Merkur Lekarski; 2001 Jul 04; 11(61):19-25. PubMed ID: 11579824
    [Abstract] [Full Text] [Related]

  • 11. Systemic release of soluble TNF receptors after high-dose TNF in isolated limb perfusion.
    Gérain J, Liénard D, Pampallona S, Baumgartner M, Rüegg C, Buurman WA, Eggermont A, Lejeune F.
    Cytokine; 1997 Dec 04; 9(12):1034-42. PubMed ID: 9417816
    [Abstract] [Full Text] [Related]

  • 12. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T, Gladalska A, Stepień H.
    Eur Cytokine Netw; 1998 Jun 04; 9(2):145-54. PubMed ID: 9681390
    [Abstract] [Full Text] [Related]

  • 13. Hemoglobin levels correlate with serum soluble CD23 and TNF-Rs concentrations in patients with rheumatoid arthritis.
    Vaiopoulos G, Boki K, Kapsimali V, Coulocheri S, Papadaki HA, Eliopoulos GD.
    Haematologia (Budap); 1998 Jun 04; 29(2):89-99. PubMed ID: 9728801
    [Abstract] [Full Text] [Related]

  • 14. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
    Ocvirk J, Stabuc B, Rudolf Z, Galvani V, Curin-Serbec V.
    Melanoma Res; 2000 Jun 04; 10(3):253-8. PubMed ID: 10890379
    [Abstract] [Full Text] [Related]

  • 15. Multifunctional regulation of the biological effects of TNF-alpha by the soluble type I and type II TNF receptors.
    Hale KK, Smith CG, Baker SL, Vanderslice RW, Squires CH, Gleason TM, Tucker KK, Kohno T, Russell DA.
    Cytokine; 1995 Jan 04; 7(1):26-38. PubMed ID: 7749064
    [Abstract] [Full Text] [Related]

  • 16. Release of soluble tumor necrosis factor receptors from polymorphonuclear cells of breast cancer patients.
    Jabłońska E, Pietruska Z.
    Arch Immunol Ther Exp (Warsz); 1997 Jan 04; 45(5-6):449-53. PubMed ID: 9437501
    [Abstract] [Full Text] [Related]

  • 17. [Investigation of soluble tumor necrosis factor receptor in patients with active tuberculosis].
    Onohara Y, Tomoda K, Nakaya M, Yoshikawa M, Tsukaguchi K, Tokuyama T, Hu A, Hukuoka K, Yamamoto C, Yoneda T, Narita N.
    Kekkaku; 1996 Jul 04; 71(7):435-8. PubMed ID: 8776958
    [Abstract] [Full Text] [Related]

  • 18. Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure.
    Nozaki N, Yamaguchi S, Shirakabe M, Nakamura H, Tomoike H.
    Jpn Circ J; 1997 Aug 04; 61(8):657-64. PubMed ID: 9276770
    [Abstract] [Full Text] [Related]

  • 19. Soluble TNF and IL-2 receptors in patients with breast cancer.
    Tesarová P, Kvasnicka J, Umlaufová A, Homolková H, Jirsa M, Tesar V.
    Med Sci Monit; 2000 Aug 04; 6(4):661-7. PubMed ID: 11208388
    [Abstract] [Full Text] [Related]

  • 20. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
    Tesar V, Jirsa M, Zima T, Kalousová M, Bartunková J, Stejskalová A, Dostál C, Zabka J.
    Med Sci Monit; 2002 Jan 04; 8(1):BR24-9. PubMed ID: 11782670
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.